StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Aurobindo Pharma Limited
NSE:AUROPHARMA.NS
Sector
Location
Market Cap
USD 8.10 B
Share Price
USD 13.27
Avg Daily Volume
1,167,775
Change (1 day)
0.20%
Change (1 year)
-19.36%
Change (YTD)
-14.90%
Aurobindo Pharma Limited Operating Cash Flow for the year ending March 31, 2025: USD 459.26 M
Aurobindo Pharma Limited Operating Cash Flow is USD 459.26 M for the year ending March 31, 2025, a 57.35% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Aurobindo Pharma Limited Operating Cash Flow for the year ending March 31, 2024 was USD 291.87 M, a 0.51% change year over year.
-
Aurobindo Pharma Limited Operating Cash Flow for the year ending March 31, 2023 was USD 290.40 M, a -56.05% change year over year.
-
Aurobindo Pharma Limited Operating Cash Flow for the year ending March 31, 2022 was USD 660.67 M, a 45.31% change year over year.
-
Aurobindo Pharma Limited Operating Cash Flow for the year ending March 31, 2021 was USD 454.65 M, a -21.80% change year over year.
Competitors
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Novo Nordisk A/S
USD 69.36
NOVO-B.CO
+0.76
1.10%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Novartis AG
USD 120.84
NOVN.SW
+0.06
0.05%
Abbott Laboratories
USD 132.03
ABT
+0.01
0.01%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Vertex Pharmaceuticals Incorporated
USD 472.35
VRTX
+3.50
0.75%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
CSL Limited
USD 163.16
CSL.AX
+5.04
3.19%
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
Regeneron Pharmaceuticals, Inc.
USD 570.59
REGN
+2.85
0.50%
MERCK Kommanditgesellschaft auf Aktien
USD 128.13
MRK.DE
-3.71
-2.82%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.98
600276.SS
+0.04
0.52%
Takeda Pharmaceutical Company Limited
USD 29.87
4502.T
+0.36
1.22%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
AbbVie Inc.
USD 191.52
ABBV
-0.93
-0.48%
Novo Nordisk A/S
USD 69.36
NOVO-B.CO
+0.76
1.10%
Roche Holding AG
USD 343.85
RO.SW
+0.20
0.06%
Novartis AG
USD 120.84
NOVN.SW
+0.06
0.05%
Abbott Laboratories
USD 132.03
ABT
+0.01
0.01%
AstraZeneca PLC
USD 143.15
AZN.L
+2.25
1.60%
Merck & Co., Inc.
USD 83.67
MRK
+0.31
0.37%
Amgen Inc.
USD 297.03
AMGN
+1.76
0.60%
Pfizer Inc.
USD 25.35
PFE
-0.30
-1.17%
Gilead Sciences, Inc.
USD 112.09
GILD
+2.45
2.23%
Vertex Pharmaceuticals Incorporated
USD 472.35
VRTX
+3.50
0.75%
Sanofi
USD 97.44
SAN.PA
+0.39
0.41%
Bristol-Myers Squibb Company
USD 47.34
BMY
+0.48
1.02%
GSK plc
USD 19.13
GSK.L
+0.13
0.71%
CSL Limited
USD 163.16
CSL.AX
+5.04
3.19%
Chugai Pharmaceutical Co., Ltd.
USD 46.16
4519.T
-0.43
-0.92%
Regeneron Pharmaceuticals, Inc.
USD 570.59
REGN
+2.85
0.50%
MERCK Kommanditgesellschaft auf Aktien
USD 128.13
MRK.DE
-3.71
-2.82%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.98
600276.SS
+0.04
0.52%
Takeda Pharmaceutical Company Limited
USD 29.87
4502.T
+0.36
1.22%